|
1
|
Kamihara J, Bourdeaut F, Foulkes WD,
Molenaar JJ, Mosse YP, Nakagawara A, Parareda A, Scollon SR,
Schneider KW, Skalet AH, et al: Retinoblastoma and neuroblastoma
predisposition and surveillance. Clin Cancer Res. 23:e98–e106.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shang Y: LncRNA THOR acts as a
retinoblastoma promoter through enhancing the combination of c-myc
mRNA and IGF2BP1 protein. Biomed Pharmacother. 106:1243–1249. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rao R and Honavar SG: Retinoblastoma.
Indian J Pediatr. 84:937–944. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Skalet AH, Gombos DS, Gallie BL, Kim JW,
Shields CL, Marr BP, Plon SE and Chévez-Barrios P: Screening
children at risk for retinoblastoma: Consensus report from the
American association of ophthalmic oncologists and pathologists.
Ophthalmology. 125:453–458. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Broaddus E, Topham A and Singh AD:
Survival with retinoblastoma in the USA: 1975–2004. Br J
Ophthalmol. 93:24–27. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stathopoulos C, Say EAT and Shields CL:
Prenatal ultrasonographic detection and prenatal (prior to birth)
management of hereditary retinoblastoma. Graefes Arch Clin Exp
Ophthalmol. 256:861–862. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bright CJ, Hawkins MM, Winter DL, Alessi
D, Allodji RS, Bagnasco F, Bárdi E, Bautz A, Byrne J, Feijen EAM,
et al: Risk of soft-tissue sarcoma among 69 460 five-year survivors
of childhood cancer in Europe. J Natl Cancer Inst. 110:649–660.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fidler MM, Reulen RC, Winter DL, Allodji
RS, Bagnasco F, Bardi E, Bautz A, Bright CJ, Byrne J, Feijen EAM,
et al: Risk of subsequent bone cancers among 69 460 five-year
survivors of childhood and adolescent cancer in Europe. J Natl
Cancer Inst. 110:22018. View Article : Google Scholar
|
|
9
|
Qaddoumi I, Bass JK, Wu J, Billups CA,
Wozniak AW, Merchant TE, Haik BG, Wilson MW and Rodriguez-Galindo
C: Carboplatin-associated ototoxicity in children with
retinoblastoma. J Clin Oncol. 30:1034–1041. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sachdeva UM and O'Brien JM: Understanding
pRb: Toward the necessary development of targeted treatments for
retinoblastoma. J Clin Invest. 122:425–434. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Andreoli MT, Chau FY, Shapiro MJ and
Leiderman YI: Epidemiological trends in 1452 cases of
retinoblastoma from the surveillance, epidemiology, and end results
(SEER) registry. Can J Ophthalmol. 52:592–598. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hudson LE, Mendoza P, Hudson WH, Ziesel A,
Hubbard GB III, Wells J, Dwivedi B, Kowalski J, Seby S, Patel V, et
al: Distinct gene expression profiles define anaplastic grade in
retinoblastoma. Am J Pathol. 188:2328–2338. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou Z, Cheng Y, Jiang Y, Liu S, Zhang M,
Liu J and Zhao Q: Ten hub genes associated with progression and
prognosis of pancreatic carcinoma identified by co-expression
analysis. Int J Biol Sci. 14:124–136. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wan Q, Tang J, Han Y and Wang D:
Co-Expression modules construction by WGCNA and identify potential
prognostic markers of uveal melanoma. Exp Eye Res. 166:13–20. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu G, Wang LG, Han Y and He QY:
ClusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: CytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moll AC, Imhof SM, Kuik DJ, Bouter LM, Den
Otter W, Bezemer PD, Koten JW and Tan KE: High parental age is
associated with sporadic hereditary retinoblastoma: The dutch
retinoblastoma register 1862–1994. Hum Genet. 98:109–112. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
de Jong MC, Kors WA, de Graaf P,
Castelijns JA, Kivelä T and Moll AC: Trilateral retinoblastoma: A
systematic review and meta-analysis. Lancet Oncol. 15:1157–1167.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dimaras H, Kimani K, Dimba EA, Gronsdahl
P, White A, Chan HS and Gallie BL: Retinoblastoma. Lancet.
379:1436–1446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
De Laurenzi V, Raschellá G, Barcaroli D,
Annicchiarico-Petruzzelli M, Ranalli M, Catani MV, Tanno B,
Costanzo A, Levrero M and Melino G: Induction of neuronal
differentiation by p73 in a neuroblastoma cell line. J Biol Chem.
275:15226–15231. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fell SM, Li S, Wallis K, Kock A, Surova O,
Rraklli V, Höfig CS, Li W, Mittag J, Henriksson MA, et al:
Neuroblast differentiation during development and in neuroblastoma
requires KIF1Bβ-mediated transport of TRKA. Genes Dev.
31:1036–1053. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gu Y, Lv F, Xue M, Chen K, Cheng C, Ding
X, Jin M, Xu G, Zhang Y, Wu Z, et al: The deubiquitinating enzyme
UCHL1 is a favorable prognostic marker in neuroblastoma as it
promotes neuronal differentiation. J Exp Clin Cancer Res.
37:2582018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jeong H, Mason SP, Barabási AL and Oltvai
ZN: Lethality and centrality in protein networks. Nature.
411:41–42. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lazarus KA, Hadi F, Zambon E, Bach K,
Santolla MF, Watson JK, Correia LL, Das M, Ugur R, Pensa S, et al:
BCL11A interacts with SOX2 to control the expression of epigenetic
regulators in lung squamous carcinoma. Nat Commun. 9:33272018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moody RR, Lo MC, Meagher JL, Lin CC,
Stevers NO, Tinsley SL, Jung I, Matvekas A, Stuckey JA and Sun D:
Probing the interaction between the histone
methyltransferase/deacetylase subunit RBBP4/7 and the transcription
factor BCL11A in epigenetic complexes. J Biol Chem. 293:2125–2136.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sleven H, Welsh SJ, Yu J, Churchill MEA,
Wright CF, Henderson A, Horvath R, Rankin J, Vogt J, Magee A, et
al: De novo mutations in EBF3 cause a neurodevelopmental syndrome.
Am J Hum Genet. 100:138–150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Parray A, Siddique HR, Kuriger JK, Mishra
SK, Rhim JS, Nelson HH, Aburatani H, Konety BR, Koochekpour S and
Saleem M: ROBO1, a tumor suppressor and critical molecular barrier
for localized tumor cells to acquire invasive phenotype: Study in
African-American and Caucasian prostate cancer models. Int J
Cancer. 135:2493–2506. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Seppala EH, Jokinen TS, Fukata M, Fukata
Y, Webster MT, Karlsson EK, Kilpinen SK, Steffen F, Dietschi E,
Leeb T, et al: LGI2 truncation causes a remitting focal epilepsy in
dogs. PLoS Genet. 7:e10021942011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zuin J, Casa V, Pozojevic J, Kolovos P,
van den Hout MCGN, van Ijcken WFJ, Parenti I, Braunholz D, Baron Y,
Watrin E, et al: Regulation of the cohesin-loading factor NIPBL:
Role of the lncRNA NIPBL-AS1 and identification of a distal
enhancer element. PLoS Genet. 13:e10071372017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao D, Zhu B, Cao X, Zhang M and Wang X:
Roles of NIPBL in maintenance of genome stability. Semin Cell Dev
Biol. 90:181–186. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
van den Berg DLC, Azzarelli R, Oishi K,
Martynoga B, Urbán N, Dekkers DHW, Demmers JA and Guillemot F:
Nipbl interacts with Zfp609 and the integrator complex to regulate
cortical neuron migration. Neuron. 93:348–361. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Siira SJ, Spahr H, Shearwood AJ,
Ruzzenente B, Larsson NG, Rackham O and Filipovska A:
LRPPRC-mediated folding of the mitochondrial transcriptome. Nat
Commun. 8:15322017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tian T, Ikeda J, Wang Y, Mamat S, Luo W,
Aozasa K and Morii E: Role of leucine-rich pentatricopeptide repeat
motif-containing protein (LRPPRC) for anti-apoptosis and
tumourigenesis in cancers. Eur J Cancer. 48:2462–2473. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Murali A, Nalinakumari KR, Thomas S and
Kannan S: Association of single nucleotide polymorphisms in cell
cycle regulatory genes with oral cancer susceptibility. Br J Oral
Maxillofac Surg. 52:652–658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rajaraman P, Wang SS, Rothman N, Brown MM,
Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Chanock SJ
and Inskip PD: Polymorphisms in apoptosis and cell cycle control
genes and risk of brain tumors in adults. Cancer Epidemiol
Biomarkers Prev. 16:1655–1661. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Litovchick L, Florens LA, Swanson SK,
Washburn MP and DeCaprio JA: DYRK1A protein kinase promotes
quiescence and senescence through DREAM complex assembly. Genes
Dev. 25:801–813. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Earl RK, Turner TN, Mefford HC, Hudac CM,
Gerdts J, Eichler EE and Bernier RA: Clinical phenotype of
ASD-associated DYRK1A haploinsufficiency. Mol Autism. 8:542017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Minegishi Y, Nakaya N and Tomarev SI:
Mutation in the zebrafish cct2 gene leads to abnormalities of cell
cycle and cell death in the retina: A model of CCT2-related leber
congenital amaurosis. Invest Ophthalmol Vis Sci. 59:995–1004. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Errico A: Cancer therapy:
Retinoblastoma-chemotherapy increases the risk of secondary cancer.
Nat Rev Clin Oncol. 11:6232014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wong JR, Morton LM, Tucker MA, Abramson
DH, Seddon JM, Sampson JN and Kleinerman RA: Risk of subsequent
malignant neoplasms in long-term hereditary retinoblastoma
survivors after chemotherapy and radiotherapy. J Clin Oncol.
32:3284–3290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Temming P, Arendt M, Viehmann A, Eisele L,
Le Guin CH, Schündeln MM, Biewald E, Mausert J, Wieland R, Bornfeld
N, et al: How eye-preserving therapy affects long-term overall
survival in heritable retinoblastoma survivors. J Clin Oncol.
34:3183–3188. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Habib LA, Francis JH, Fabius AW, Gobin PY,
Dunkel IJ and Abramson DH: Second primary malignancies in
retinoblastoma patients treated with intra-arterial chemotherapy:
The first 10 years. Br J Ophthalmol. 102:272–275. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Temming P, Arendt M, Viehmann A, Eisele L,
Le Guin CH, Schundeln MM, Biewald E, Astrahantseff K, Wieland R,
Bornfeld N, et al: Incidence of second cancers after radiotherapy
and systemic chemotherapy in heritable retinoblastoma survivors: A
report from the German reference center. Pediatr Blood Cancer.
64:71–80. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shi K, Bing ZT, Cao GQ, Guo L, Cao YN,
Jiang HO and Zhang MX: Identify the signature genes for diagnose of
uveal melanoma by weight gene co-expression network analysis. Int J
Ophthalmol. 8:269–274. 2015.PubMed/NCBI
|
